The effect of an evening dose of a long-acting beta-blocker on the autonomic tone in patients with congestive heart failure

Kardiologia Polska

Volumn 67, Issue 9, 2009, Pages 963-970

  Targoński, Ryszard ^a   Sadowski, Janusz ^b  

^a UNIVERSITY OF WARMIA AND MAZURY IN OLSZTYN   (Poland)

^b City Hospital   (Poland)

Author keywords

Autonomic nervous system; Beta blockade; Heart failure; Heart rate

Indexed keywords

BISOPROLOL; LONG ACTING DRUG;

ADULT; AGED; ARTICLE; AUTONOMIC NERVOUS SYSTEM FUNCTION; BETA ADRENERGIC RECEPTOR BLOCKING; CIRCADIAN RHYTHM; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; EVENING DOSAGE; FEMALE; HEART RATE VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MORNING DOSAGE; RR INTERVAL; SINUS RHYTHM;

EID: 72449130634     PISSN: 00229032     EISSN: 00229032     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Hasking GJ, Esler MD, Jennings GL, et al. Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity. Circulation 1986; 73: 615-621
2. Fries R, Hein S, Konig J. Reversed circadian rhythms of heart rate variability and morning peak occurrence of sustained ventricular tachyarrhythmias in patients with implanted cardioverter defibrillator. Med Sci Monit 2002; 8: CR751-6.
3. CIBIS-II Investigators and Committees: The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet 1999; 353: 9-13.
4. Willenheimer R, van Veldhuisen DJ, Silke B, et al; CIBIS III Investigators. Effect on survival and hospitalization of initiating treatment for chronic heart failure with bisoprolol followed by enalapril, as compared with the opposite sequence: results of the randomized Cardiac Insufficiency Bisoprolol Study (CIBIS) III. Circulation 2005; 112: 2426-2435 (Pubitemid 41504492)
5. MERIT-HF Investigators. Effect of metoprolol CR/XL in chronic heart failure: metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 1999; 353: 2001-2007 (Pubitemid 29271744)
6. Poole-Wilson PA, Swedberg K, Cleland JGF, et al. Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial. Lancet 2003; 362: 7-13. (Pubitemid 36835815)
7. Malik M, Camm AJ. Heart rate variability: from facts to fancies. J Am Coll Cardiol 1993; 22: 566-568 (Pubitemid 23214573)
8. Nolan J, Batin PD, Andrews R, et al. Prospective Study of Heart Rate Variability and Mortality in Chronic Heart Failure. Results of the United Kingdom Heart Failure Evaluation and Assessment of Risk Trial (UK-Heart). Circulation 1998; 98: 510-516
9. Soejima K, Akaishi M, Meguro T, et al. Age-adjusted heart rate variability as an index of the severity and prognosis of heart failure. Jpn Circ J 2000; 64: 32-38 (Pubitemid 30073659)
10. Van de Borne P, Montno N, Pagani M, et al. Absence of low-frequency variability of sympathetic nerve activity in severe heart failure. Circulation 1997; 95: 1449-1454 (Pubitemid 27142802)
11. Cooley RL, Montano N, Cogliati C, et al. Evidence for a central origin of the low-frequency oscillation in RR-interval variability. Circulation 1998; 98: 556-561 (Pubitemid 28371254)
12. Schönauer M, Thomas A, Morbach S, et al. Cardiac autonomic diabetic neuropathy. Diab Vasc Dis Res 2008; 5: 336-344
13. The Task Force of the European Society of Cardiology and the North American Society of Pacing Electrophysiology (ESC and NASPE). Heart rate variability - standards of measurement, physiological interpretation and clinical use. Circulation 1996; 93: 1043-1065
14. Vanoli E, Funck-Brentano C, Hansen S, et al. Abstract of the XXII Congress of The European Society of Cardiology: Nocturnal death in heart failure: effects of bisoprolol. 2000 Amsterdam; abstract.
15. Proclemer A, Ghidina M. Application of the main implantable cardioverter-defibrillator trials and the 2006 Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death. J Cardiovasc Med (Hagerstown) 2007; 8: 320-323
16. Galinier M, Pathak A, Fourcade J, et al. Depressed low frequency power of heart rate variability as an independent predictor of sudden death in chronic heart failure. Eur Heart J 2000; 21: 475-482 (Pubitemid 30122135)
17. R. Ferrari, S. Censi, F. Mastrorilli, et al. Prognostic benefits of heart rate reduction in cardiovascular disease. Eur Heart J Suppl 2003; 5: G10-4.
18. Lechat P, Hulot JS, Escolano S, et al.; on behalf of the CIBIS II Investigators: Heart Rate and Cardiac Rhythm Relationships With Bisoprolol Benefit in Chronic Heart Failure in CIBIS II Trial. Circulation 2001; 103: 1428.
19. Nagatsu M, Spinale FG, Koide M, et al. Bradycardia and the role of beta-blockade in the amelioration of left ventricular dysfunction. Circulation 2000; 101: 653-659 (Pubitemid 30094737)
20. Lechat P. Beta-blocker treatment in heart failure. Role of heart rate reduction. Basic Res Cardiol 1998; 93: 148-155 (Pubitemid 28499482)
21. Di Lenarda A, Sabbadini G, Moretti M, et al.; on behalf of Heart Muscle Disease Study Group. Effect of carvedilol versus metoprolol immediate release on 24-hour heart rate in patients with idipathic dilated cardiomiopathy. E 1-year cross-over study. Eur J Heart Fail 2004; 3 (Suppl. 1): abstract.
22. Bullinga JR, Alharethi R, Schram MS, et al. Changes in heart rate variability are correlated to hemodynamic improvement with chronic CARVEDILOL therapy in heart failure. J Card Fail 2005; 11: 693-699 (Pubitemid 41797499)